Document Detail


Rendu-Osler-Weber disease: experience with 56 patients.
MedLine Citation:
PMID:  12402665     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Rendu-Osler-Weber disease, or hereditary hemorrhagic telangiectasia (HHT), is an autosomal dominant disease characterized by systemic vascular dysplasia. The prevalence varies and ranges, according to region, from 1/3500 to 1/5000. Data concerning Italy are not available. The diagnosis is based on the following criteria: family history, epistaxis, telangiectases and visceral arteriovenous malformations. The diagnosis is to be considered definite if three criteria are present and suspected if two criteria are present. From September 2000 to March 2002, 100 patients (63 males, 37 females, mean age 45.5 +/- 17.3 years) potentially affected by HHT were evaluated in the HHT Center of the "Augusto Murri" Internal Medicine Section at the University of Bari (on a day-hospital or hospitalization basis). The diagnosis of HHT was confirmed in 56 patients and suspected in 10. Magnetic resonance imaging revealed cerebral arteriovenous malformations in 8.5% of patients. In 14.6% of patients contrast echocardiography revealed pulmonary arteriovenous malformations subsequently confirmed at multislice computed tomography in all cases but one. In 48.2% of subjects hepatic vascular malformations were revealed by echo color Doppler ultrasonography, whereas abdominal multislice computed tomography was positive in 63.8% of patients. In 64% of the 25 patients, who underwent endoscopy, gastric telangiectases were found. In 3 out of 6 patients presenting with pulmonary arteriovenous malformations, embolotherapy was performed with success. In our patients, the use of tranexamic acid caused a reduction in the frequency of epistaxis. The future objectives of the HHT Center of Bari are to increase knowledge of the disease, to cooperate with other centers with the aim of increasing the number of patients studied and to avoid the limits of therapeutic and diagnostic protocols of a rare disease such as HHT.
Authors:
Carlo Sabbà; Giovanna Pasculli; Anna Cirulli; Mauro Gallitelli; Giovanna Virgilio; Edoardo Guastamacchia; Francesco Resta; Giuseppe Palasciano
Related Documents :
25178435 - Distribution of il-10 family cytokines in serum and synovial fluid of patients with inf...
25477775 - Negative bold in default-mode structures measured with eeg-mreg is larger in temporal t...
19956935 - Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encep...
25364525 - Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the ...
19910565 - Peritoneal small solute clearance is nonlinearly related to patient survival in the aus...
12632425 - A short course of bg9588 (anti-cd40 ligand antibody) improves serologic activity and de...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna     Volume:  17     ISSN:  0393-9340     ISO Abbreviation:  Ann. Ital. Med. Int.     Publication Date:    2002 Jul-Sep
Date Detail:
Created Date:  2002-10-29     Completed Date:  2002-12-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8806705     Medline TA:  Ann Ital Med Int     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  173-9     Citation Subset:  IM    
Affiliation:
Centro Interdipartimentale Universitario per lo Studio e la Ricerca sul Morbo di Rendu-Osler-Weber, Bari. c.sabba@dimimp.uniba.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Diagnostic Imaging
Embolization, Therapeutic
Epistaxis / drug therapy,  etiology
Female
Hemorrhage / drug therapy,  etiology
Hemostatics / therapeutic use
Humans
Italy / epidemiology
Magnetic Resonance Imaging
Male
Middle Aged
Retrospective Studies
Telangiectasia, Hereditary Hemorrhagic / complications,  diagnosis,  drug therapy,  epidemiology*
Tranexamic Acid / therapeutic use
Chemical
Reg. No./Substance:
0/Hemostatics; 1197-18-8/Tranexamic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and mi...
Next Document:  Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingr...